Cell Therapy Startup, Seraxis, secures Series A Funding.
About Seraxis, Inc.
Seraxis is a private biotechnology company launched in 2013 and located in Germantown, Maryland. The Seraxis mission is to develop a practical and potent cell replacement therapy for insulin-dependent diabetes.
